Evaxion Biotech As Stock Buy Hold or Sell Recommendation
| EVAX Stock | USD 2.47 0.92 27.14% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Evaxion Biotech AS is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Evaxion Biotech AS given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Evaxion Biotech AS, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Evaxion Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Evaxion and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Evaxion |
Execute Evaxion Biotech Buy or Sell Advice
The Evaxion recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Evaxion Biotech AS. Macroaxis does not own or have any residual interests in Evaxion Biotech AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Evaxion Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Evaxion Biotech Trading Alerts and Improvement Suggestions
| Evaxion Biotech AS generated a negative expected return over the last 90 days | |
| Evaxion Biotech AS has high historical volatility and very poor performance | |
| Evaxion Biotech AS has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 73 K. Net Loss for the year was (22.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evaxion Biotech AS currently holds about 25.25 M in cash with (17.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06. | |
| Evaxion Biotech AS has a poor financial position based on the latest SEC disclosures | |
| Roughly 25.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Mercks VC Arm Backs Evaxion Biotech in 10.8M Strategic Investment Round - StockTitan |
Evaxion Biotech Returns Distribution Density
The distribution of Evaxion Biotech's historical returns is an attempt to chart the uncertainty of Evaxion Biotech's future price movements. The chart of the probability distribution of Evaxion Biotech daily returns describes the distribution of returns around its average expected value. We use Evaxion Biotech AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Evaxion Biotech returns is essential to provide solid investment advice for Evaxion Biotech.
| Mean Return | -1.69 | Value At Risk | -22.43 | Potential Upside | 13.19 | Standard Deviation | 13.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Evaxion Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Evaxion Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Evaxion Biotech, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Evaxion Biotech AS back and forth among themselves.
| Shares | Armistice Capital, Llc | 2024-09-30 | 483 K | Invst Llc | 2024-09-30 | 43.2 K | Citadel Advisors Llc | 2024-09-30 | 14.8 K | Beacon Capital Management, Llc | 2024-09-30 | 4.9 K | Blackrock Inc | 2024-09-30 | 1.5 K | Jpmorgan Chase & Co | 2024-09-30 | 780 | Rhumbline Advisers | 2024-09-30 | 290 | Southstate Corp | 2024-09-30 | 4.0 | Tower Research Capital Llc | 2024-06-30 | 0.0 |
Evaxion Biotech Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 2.5M | (1.9M) | 1.5M | 1.0 | 0.9 | 0.86 | |
| Investments | (393K) | (1.3M) | (268K) | (93K) | (83.7K) | (87.9K) | |
| Change In Cash | (3.7M) | 26.3M | (19.0M) | (7.6M) | (6.8M) | (6.5M) | |
| Free Cash Flow | (12.8M) | (23.3M) | (26.1M) | (17.8M) | (16.0M) | (16.8M) | |
| Depreciation | 105K | 344K | 571K | 615K | 707.3K | 742.6K | |
| Other Non Cash Items | 919K | (171K) | (243K) | 2.8M | 3.2M | 3.3M | |
| Capital Expenditures | 393K | 1.4M | 292K | 87K | 100.1K | 95.0K | |
| Net Income | (15.0M) | (24.5M) | (23.2M) | (22.1M) | (19.9M) | (20.9M) | |
| End Period Cash Flow | 5.8M | 32.2M | 13.2M | 5.6M | 6.4M | 6.1M |
Evaxion Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Evaxion Biotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Evaxion Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Evaxion stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.68 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 14.65 | |
Ir | Information ratio | -0.13 |
Evaxion Biotech Volatility Alert
Evaxion Biotech AS is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Evaxion Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Evaxion Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Evaxion Biotech Fundamentals Vs Peers
Comparing Evaxion Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Evaxion Biotech's direct or indirect competition across all of the common fundamentals between Evaxion Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Evaxion Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Evaxion Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Evaxion Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Evaxion Biotech to competition |
| Fundamentals | Evaxion Biotech | Peer Average |
| Return On Equity | -8.03 | -0.31 |
| Return On Asset | -0.69 | -0.14 |
| Operating Margin | (0.57) % | (5.51) % |
| Current Valuation | 8.1 M | 16.62 B |
| Shares Outstanding | 5.58 M | 571.82 M |
| Shares Owned By Insiders | 25.20 % | 10.09 % |
| Shares Owned By Institutions | 8.16 % | 39.21 % |
| Number Of Shares Shorted | 102.32 K | 4.71 M |
| Price To Book | 75.74 X | 9.51 X |
| Price To Sales | 1.70 X | 11.42 X |
| Revenue | 73 K | 9.43 B |
| EBITDA | (21.4 M) | 3.9 B |
| Net Income | (22.12 M) | 570.98 M |
| Cash And Equivalents | 25.25 M | 2.7 B |
| Cash Per Share | 1.06 X | 5.01 X |
| Total Debt | 10.87 M | 5.32 B |
| Debt To Equity | 0.48 % | 48.70 % |
| Current Ratio | 6.47 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (17.69 M) | 971.22 M |
| Short Ratio | 2.07 X | 4.00 X |
| Earnings Per Share | (2.80) X | 3.12 X |
| Target Price | 10.85 | |
| Number Of Employees | 49 | 18.84 K |
| Beta | -0.23 | -0.15 |
| Market Capitalization | 13.28 M | 19.03 B |
| Total Asset | 12.89 M | 29.47 B |
| Retained Earnings | (107.97 M) | 9.33 B |
| Working Capital | 1.27 M | 1.48 B |
| Net Asset | 12.89 M |
Evaxion Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Evaxion . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 139831.0 | |||
| Daily Balance Of Power | (3.41) | |||
| Rate Of Daily Change | 0.73 | |||
| Day Median Price | 2.49 | |||
| Day Typical Price | 2.48 | |||
| Price Action Indicator | (0.47) | |||
| Period Momentum Indicator | (0.92) |
About Evaxion Biotech Buy or Sell Advice
When is the right time to buy or sell Evaxion Biotech AS? Buying financial instruments such as Evaxion Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Evaxion Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Retail Thematic Idea Now
Retail
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.